- TV Footage
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Social Media
- Background Information
- Media Contact
Leverkusen, August 8, 2017 – In a VIP visit to the Bayer Communication Center, a delegation of players, trainers and officials from Bayer 04 Leverkusen Fußball GmbH exchanged their jerseys for lab coats and undertook an exciting tour of the world of Bayer research. The program encompassed a mix of theory and interesting facts, interactive terminals and hands-on experimentation. Following a tour of the various interactive terminals, 18-year-old midfielder Kai Havertz experienced the problems of old age as he tried to take tablets wearing a special suit which simulates what it’s like to be 80. This demonstrated to the players how aging restricts mobility and dexterity. Trainer Heiko Herrlich used the rare opportunity to extract his own DNA in the Baylab student laboratory.
“Today we learned a lot about the history and areas of activity of a global enterprise,” commented captain Lars Bender. “It has made us particularly aware of the strong bond between our club and Bayer.”
“We all really enjoyed the program,” added Michael Schade, Managing Director of Bayer 04. “It showed us practical responses to societal challenges in the areas of health and nutrition. So that our people can identify with Bayer and Bayer 04, it’s good for them to know what issues the company is working on and how it actually contributes to improving people’s quality of life.” Tongue in cheek Schade then added that Heiko Herrlich had proved he now carries the Bayer 04 gene.
Baykomm - the Bayer Communication Center
The newly redesigned Baykomm uses interactive terminals to enable visitors to discover Bayer and its areas of focus. Digital media and activity stations located in open-plan rooms foster active participation and experimentation. Three special info sections explore the themes of teamwork, the media and corporate identity. Science Boards can be used to access interesting facts and fascinating images relating to Bayer’s key focuses of science and life. In this fun and entertaining way, Baykomm communicates the company’s mission of “Science For A Better Life.” Baykomm is open to the public from Monday through Friday between 10 a.m. and 6 p.m.
Bayer: Science For A Better Life
Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.
Note to editors:
Photos will be available from 6:30 p.m. on www.press.bayer.com
For social media users:
Visit Bayer on Facebook at: www.facebook.com/Bayer
Follow us on Twitter at: www.twitter.com/Bayer
Find more information at www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.